nach oben

PharmacoEconomics

Erschienen in:

01.07.2007 | Correspondence

Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries

verfasst von: Liu Bao Peng, Chong Qing Tan, Xiao Min Wan, Wei Cui

Erschienen in: PharmacoEconomics | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Excerpt

Many countries have adopted cost-utility analysis to evaluate the costs and outcomes associated with new drugs. In China, the National Center for Pharmacoeconomics (NCPE) places great emphasis on the use of cost-utility analysis. However, some of the patients and medical personnel in China do not presently consider cost-utility analysis to be important, and pharmacoeconomic studies in China are still difficult to conduct. In particular, it is difficult to evaluate the quality of life of patients in China; hence, the use of cost-utility analysis is limited. Indeed, to date we know of only a few published cost-utility analyses[1‐3] of a treatment from a Chinese perspective. …

You JH, Sahota DS, MoYuen P. A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia. Hum Reprod 2006 Jul; 21 (7): 1878–1883PubMedCrossRef

Xu D, Chen G, Li S, et al. Combined high dose leucovorin and 5-fluorouracil continuous infusion for head-neck and digestive tract cancers. Zhonghua Zhong Liu Za Zhi 2002 Jan; 24 (1): 93–95PubMed

Wang PC, Chu CC, Liang SC, et al. Cost-utility for endoscopic sinus surgery. Otolaryngol Head Neck Surg 2004 Jan; 130 (1): 31–38PubMedCrossRef

Titel: Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries
verfasst von: Liu Bao Peng
Chong Qing Tan
Xiao Min Wan
Wei Cui
Publikationsdatum: 01.07.2007
Verlag: Springer International Publishing
Erschienen in: PharmacoEconomics / Ausgabe 7/2007
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI: https://doi.org/10.2165/00019053-200725070-00007

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Cost-Utility Analysis in China: Differences and Difficulties Compared with Developed Countries

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2007

Perspectives on Dynamic Optimisation and Control Theory in Treating Hyperlipidaemia

A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma

Cost Considerations in the Treatment of Colorectal Cancer

Retrospective Economic and Outcomes Analyses Using Non-US Databases

Direct and Indirect Costs Attributable to Alcohol Consumption in Germany

The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis